Tilray | TRLY - Ebitda





Ebitda Veränderung Datum
Acasti Pharma USD -3.01M 562K 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Avita Medical AUD -9.69M 12.21M 2025-12
Canopy Growth CAD -137M 134.13M 2026-03
Cronos Group USD -1.41M 1.86M 2026-03
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 9.34B 440M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Moderna USD -790M 582M 2025-12
Organigram Holdings CAD -4.76M 10.02M 2026-03
Organon & Co USD 415M 32M 2026-03
Revvity USD 272.91M 24M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1.05B 46.4M 2026-03
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03
Zealand Pharma A/S -727.47M 285.54M 2025-12